CLINICAL_TRIALS
research
· 2025-02-19
Clinical Trial Update: Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomatic Paroxysmal AF [Phase 4]
Summary
A Phase 4 clinical trial update compares PolarX and Arctic Front cryoballoons for pulmonary vein isolation in symptomatic paroxysmal atrial fibrillation; the st…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Paroxysmal Atrial Fibrillation | Phase 4 | Status: ACTIVE_NOT_RECRUITING